Week51, 2020
1. Seasonal influenza activity in the U.S. remains unusually low; 0.3% of respiratory specimens tested positive for influenza at clinical labs.
2. Of the positive specimens reported, 35.1% were Influenza A and 64.9% were Influenza B in clinical labs, while public health labs reported 100% as Influenza A (H1N1 subtype).
3. Outpatient visits for influenza-like illness (ILI) remained stable at 1.6%, below the national baseline of 2.6%, with minimal ILI activity reported in most jurisdictions.
4. 13.6% of deaths were attributed to pneumonia, influenza, or COVID-19 (PIC), exceeding the epidemic threshold of 6.8%, with most attributed to COVID-19.
5. No new influenza-associated pediatric deaths were reported, keeping the season total at one.
6. A total of 101 laboratory-confirmed influenza-associated hospitalizations have been reported this season, at lower levels than typical for this time of year.
7. Vaccination is strongly encouraged as the best method to prevent serious complications, though trends in vaccine uptake were not specified.
8. Healthcare-seeking behaviors and ILI reporting remain influenced by the COVID-19 pandemic, limiting traditional surveillance accuracy.
9. Virologic surveillance indicates lower-than-normal flu activity, despite an increased number of tests conducted compared to previous seasons.
10. CDC advises that flu activity may increase in the coming months, though key factors like COVID-19 and healthcare changes make predictions uncertain.